Skip to main content
Excell Industries Ltd. logo

Excell Industries Ltd. — Investor Relations & Filings

Ticker · EXCELINDUS ISIN · INE369A01029 LEI · 335800JQL36IBXSAGQ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,107 across all filing types
Latest filing 2021-11-12 Regulatory Filings
Country IN India
Listing BSE.NS EXCELINDUS

About Excell Industries Ltd.

https://www.excelind.co.in/

Excell Industries Ltd. focuses on the production of specialty chemicals, agrochemical intermediates, and performance chemicals. The organization operates through distinct divisions dedicated to chemical manufacturing and environmental management. Its portfolio features phosphorus derivatives, polymer additives, and intermediates for the pharmaceutical sector. Beyond chemical production, the company provides integrated solutions for solid waste management, utilizing proprietary technologies for organic waste conversion and bio-remediation. The company prioritizes research and development to drive process innovation and sustainable manufacturing practices, supporting diverse applications across the agricultural, industrial, and environmental sectors.

Recent filings

Filing Released Lang Actions
Dear Sir, Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that at the meeting of the Board of Directors ....
Regulatory Filings
2021-11-12 English
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of unaudited financial results for the quarter and half year ended September 30, 2021, including a limited review report by auditors Price Waterhouse Chartered Accountants LLP. It contains comprehensive financial data such as income, expenses, profit, tax, and earnings per share, along with notes to the financial results. The document references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The presence of actual financial statements and substantive financial data confirms this is an Interim / Quarterly Report rather than a mere announcement or certification. The document length (15,000 characters) and content depth support classification as an Interim / Quarterly Report (IR). H1 2022
2021-11-12 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization of securities for the quarter ended 30th September 2021. It is addressed to stock exchanges and includes a certification from the company secretary. The document is short (2226 characters) and primarily a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications and compliance documents that do not qualify as full reports or announcements.
2021-10-18 English
We hereby confirm and certify that: a. The securities received from Depositories for dematerialization during the quarter ended 30th September, 2021, were confirmed (accepted/ ....
Regulatory Filings
2021-10-18 English
Dear Sir/ Madam, In continuation of our letter dated 30th September, 2021, for closure of trading window for the aforesaid purpose, the Trading Window for trading in Company's ....
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended 30th September 2021. It is a formal announcement sent to stock exchanges as per SEBI regulations. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing about the upcoming board meeting and trading window closure. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement about the board meeting and compliance with insider trading rules.
2021-10-18 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended 30th September 2021. It is addressed to stock exchanges and mentions regulatory compliance under SEBI Listing Obligations. The document does not contain actual financial data or results but is an announcement of an upcoming board meeting and related trading window closure. The document length is short (2433 characters) and it serves as a notification rather than a report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice, not as an Interim Report or Earnings Release.
2021-10-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.